Lineage, Inc. Common Stock (LINE)vsRayonier Inc (RYN)
LINE
Lineage, Inc. Common Stock
$37.75
+0.96%
REAL ESTATE · Cap: $9.50B
RYN
Rayonier Inc
$20.22
-0.30%
REAL ESTATE · Cap: $6.12B
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 455% more annual revenue ($5.37B vs $968.29M). RYN leads profitability with a 7.8% profit margin vs -3.1%. RYN earns a higher WallStSmart Score of 49/100 (D+).
LINE
Avoid35
out of 100
Grade: F
RYN
Hold49
out of 100
Grade: D+
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Reasonable price relative to book value
Revenue surging 272.1% year-over-year
Areas to Watch
0.8% revenue growth
0.0% earnings growth
Operating margin of 3.7%
Elevated debt levels
Distress zone — elevated risk
7.8% margin — thin
Expensive relative to growth rate
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : RYN
The strongest argument for RYN centers on Price/Book, Revenue Growth. Revenue growth of 272.1% demonstrates continued momentum.
Bear Case : LINE
The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.
Bear Case : RYN
The primary concerns for RYN are Altman Z-Score, Profit Margin, PEG Ratio. A P/E of 44.5x leaves little room for execution misses.
Key Dynamics to Monitor
LINE profiles as a turnaround stock while RYN is a hypergrowth play — different risk/reward profiles.
RYN carries more volatility with a beta of 0.90 — expect wider price swings.
RYN is growing revenue faster at 272.1% — sustainability is the question.
LINE generates stronger free cash flow (186M), providing more financial flexibility.
Bottom Line
RYN scores higher overall (49/100 vs 35/100) and 272.1% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm dedicated to regenerative medicine, focusing on next-generation cell therapies targeting ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust strategic collaborations, Lineage is at the forefront of developing transformative treatment options that aim to improve patient outcomes significantly. The company's commitment to enhancing its diverse product pipeline and expediting clinical trials makes it an attractive investment opportunity for institutional investors seeking exposure in the rapidly evolving healthcare landscape.
Visit Website →Rayonier Inc
REAL ESTATE · REIT - SPECIALTY · USA
Rayonier is a leading timber real estate investment trust with assets located in some of the most productive softwood producing regions in the United States and New Zealand.
Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?